在实验性败血栓冲击中,雷宁-血管酶系统的改变
Bruno Garcia1,2, Benoit Ter Schiphorst1,2, Fuhong Su1
1Experimental Laboratory of the Department of Intensive Care, Erasme University Hospital, Hôpitaux Universitaires de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
Critical care explorations
|October 15, 2024
概括
这项研究揭示了在败血症休克期间氨酸 - 血管增生酶系统 (RAS) 的动态变化,显示了血管增生酶转化酶 (ACE) 活性降低和向血管增生酶 - 1 - 7轴转移,表明了适应性反应.
科学领域:
- 心血管生理学心血管生理学
- 脏生理学 脏生理学
- 临界护理医学 临界护理医学
背景情况:
- 胺-血管素系统 (RAS) 在调节血压和液体平衡方面发挥着至关重要的作用.
- RAS的调节失调与败血症休克的病理生理学有关.
- 了解败血症期间的动态RAS变化对于开发有效的治疗方法至关重要.
研究的目的:
- 为了研究在实验性败血性休克期间,-血管素系统 (RAS) 的动态变化.
- 专门分析血管素转化酶 (ACE) 活性和血管素的平衡.
- 阐明血管酶-1-7轴在败血症休克中的作用.
主要方法:
- 在猪体内通过腹膜炎建立了败血症休克的实验模型.
- 在四十个时间点从八只机械通风的猪身上收集了血液样本.
- 用质谱测量测量了血管素和ACE活性的血水平.
主要成果:
- 败血休克诱导导致血雷宁活性增加,血管新生素I和血管新生素II水平.
- 从复苏后4小时观察到血管酶转化酶 (ACE) 活性显著下降.
- 血管新生素I/血管新生素II比率增加,并注意到向血管新生素-1-7轴的转移.
结论:
- 败血性休克的特点是RAS的动态变化,包括降低ACE活性和转移到血管素-(1-7) 轴.
- 这些发现表明,在败血症期间,RAS内部存在适应性反应.
- 这项研究提供了对管理败血症休克的潜在治疗点的见解.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
01:25Antihypertensive Drugs: Direct Renin Inhibitors
505
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
505
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
490
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
490
01:33Hormonal Regulation
33.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.0K
01:29Hypertension II: Pathophysiology
2
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
2
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
595
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
595